Rebooting generics to fight cancer | Talking Precision Medicine #21
31/8/2020
0:00
51:12
Reboot Rx is a different kind of biotech startup. Reboot’s mission is to find generic non-cancer drugs that can benefit cancer patients quickly and affordably. And as a not-for-profit, Reboot can stay focused on its mission. Given the number of paradigms Reboot hopes to shift at once, we decided to talk with all three co-founders: CEO Laura Kleiman, COO & CTO Pradeep Mangalath and CSO Catherine Del Vecchio Fitz. Each one provides perspective on their part of the puzzle.
Visit TPM E21 for highlights and links from this episode.
Otros episodios de "Talking Precision Medicine"
No te pierdas ningún episodio de “Talking Precision Medicine”. Síguelo en la aplicación gratuita de GetPodcast.